MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX)

MacroGenics, Inc. downgraded to Hold after B7-H3 ADC setbacks; assess MGC026 phase 1 catalysts, pipeline risks, and liquidity outlook—click for this MGNX update.

Read on WOBR AI →